News Digging > Technology > US FDA approves Novartis’ Tafinlar and Mekinist combination therapy
US FDA approves Novartis’ Tafinlar and Mekinist combination therapy
US FDA approves Novartis’ Tafinlar and Mekinist combination therapy,The US FDA has granted approval for Novartis’ combination therapy, Tafinlar (dabrafenib) and Mekinist (trametinib), to treat BRAF V600E LGG.

US FDA approves Novartis’ Tafinlar and Mekinist combination therapy

The US FDA has granted approval for Novartis’ combination therapy, Tafinlar (dabrafenib) and Mekinist (trametinib), to treat BRAF V600E LGG.